| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Doxorubicin | CTRPv2 | pan-cancer | AAC | -0.2 | 2e-08 |
| mRNA | CD-437 | CTRPv2 | pan-cancer | AAC | -0.22 | 2e-08 |
| mRNA | leptomycin B | CTRPv2 | pan-cancer | AAC | -0.22 | 3e-08 |
| mRNA | SCH-79797 | CTRPv2 | pan-cancer | AAC | -0.24 | 4e-08 |
| mRNA | SNX-2112:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.22 | 4e-08 |
| mRNA | BRD-K66453893 | CTRPv2 | pan-cancer | AAC | -0.21 | 5e-08 |
| mRNA | paclitaxel | CTRPv2 | pan-cancer | AAC | -0.22 | 5e-08 |
| mRNA | GW843682X | CTRPv2 | pan-cancer | AAC | -0.22 | 8e-08 |
| mRNA | YK 4-279 | CTRPv2 | pan-cancer | AAC | -0.2 | 1e-07 |
| mRNA | Docetaxel | CTRPv2 | pan-cancer | AAC | -0.31 | 1e-07 |